Clinical Trial Update: Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane [NA]

View source ↗

Summary

This clinical trial evaluated a high flux cellulose triacetate membrane for removing uremic toxins during haemodialysis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: University Hospital, Ghent | Conditions: Haemodialysis | NA | Status: COMPLETED